Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. - Wikidata - wikimedia - TriplyDB

Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

http://www.wikidata.org/entity/Q34714991

about

Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives White matter hyperintensities, cognitive impairment and dementia: an update.Longitudinal change of small-vessel disease-related brain abnormalities Mild cognitive impairment, poor episodic memory, and late-life depression are associated with cerebral cortical thinning and increased white matter hyperintensities.White matter hyperintensities and imaging patterns of brain ageing in the general population.Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease.Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated Daytime Sleepiness and Sleep Inadequacy as Risk Factors for Dementia.Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways.Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.Mediterranean diet and brain structure in a multiethnic elderly cohort.The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.Preclinical Cerebral Network Connectivity Evidence of Deficits in Mild White Matter Lesions APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL Sleep Disordered Breathing and White Matter Hyperintensities in Community-Dwelling Elders.Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease.Late-life memory trajectories in relation to incident dementia and regional brain atrophy.White matter integrity as a mediator in the relationship between dietary nutrients and cognition in the elderly Sleep Duration and White Matter Quality in Middle-Aged Adults.Dementia risk and prevention by targeting modifiable vascular risk factors.Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia.White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study.Baseline White Matter Hyperintensities and Hippocampal Volume are Associated With Conversion From Normal Cognition to Mild Cognitive Impairment in the Framingham Offspring Study.Executive Functions in Healthy Older Adults Are Differentially Related to Macro- and Microstructural White Matter Characteristics of the Cerebral Lobes.Comparative proteomic analyses of the parietal lobe from rhesus monkeys fed a high-fat/sugar diet with and without resveratrol supplementation, relative to a healthy diet: Insights into the roles of unhealthy diets and resveratrol on function.White matter signal abnormalities in former National Football League players.An inflammation-related nutrient pattern is associated with both brain and cognitive measures in a multiethnic elderly population.Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by the hippocampal volume or white matter hyperintensities.Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly.Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes.White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.White matter abnormalities and cognition in patients with conflicting diagnoses and CSF profiles.Molecular Mechanisms of Oligodendrocyte Regeneration in White Matter-Related Diseases.An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease

P2860

Q28077809-C9526016-D48F-4937-A561-52F69252F078 Q30893715-F478F40D-A986-4BC2-8DA4-BB24C372B09E Q30938195-282C21B3-5033-41FE-AAA1-559347BA21EA Q34471412-D2F5E6F9-264F-41A8-BEF3-347733C6048A Q34515561-7D4F995E-D978-4F91-B785-043125A951B1 Q34675934-23984803-7ECB-4160-80EF-868E2F9F8064 Q35604010-D23AD835-730E-4BD1-B2BC-02BA1968823A Q35905448-9DAA1A4B-9E77-4E88-BDA3-E193AC69E82D Q35999988-9F1B6995-5C41-4109-AD48-8A172385D6D4 Q36260136-D1A9BD8B-9F12-47E2-8669-74B92D689235 Q36300050-3D85A628-982E-45C2-A715-9104BF55AB37 Q36366566-FDD9384E-3368-4450-B6C3-17CC262ECF9F Q36590984-4698CE8D-4231-4B5F-B78D-C24916359FCB Q36593238-E169D841-3A0F-4273-BCFE-08675320E05E Q36686478-0A25DC67-B7A1-42E3-80AF-0E675CC6BD05 Q36694586-3A280E91-1E5C-451D-B8D6-9F46B2320F38 Q36763000-82305A15-9C38-43D4-8D86-38520B267965 Q36944854-F4F05414-3D86-456F-A694-D6F8E05E4D10 Q37185075-C06B73B8-1F0C-4758-AC98-3A81F614A53C Q38653373-4122F8F4-8F33-4643-87D9-6FCC0971F641 Q38949866-1086D1EC-E845-4EAF-9467-BB19B4D83921 Q39421399-0D1E3C03-EC00-4411-8E05-89115BA1D110 Q39888008-054AB744-C90C-4FFC-B9AE-4E45332878E0 Q40032135-8C4E4B54-4C10-4CE6-8403-2FE75E5EBDC0 Q40101067-C1010C6F-7264-4BE7-9688-D2F78C5BEE62 Q40247826-CECC6B6B-466F-4BD7-A7B6-D9EE238D948E Q46730906-657C1204-7CC5-45BD-B7BA-E0AB6A8F05A5 Q47134332-ABFD7A34-9E87-48C3-891E-0195C24FC561 Q47145007-898A87FA-3047-46E0-8C74-D5FDA5E526FE Q47153591-686912F6-8563-42C9-89AD-0B18F928F001 Q47234719-7CB075D5-500A-452A-B9ED-D74F77D918DF Q47562288-CADE738E-60E9-49C6-AEDA-98246057AE0D Q49990629-89A53E23-2E44-42B2-AEC2-AA7CCA11C1B9 Q50207666-B08E8C65-87BA-4145-8147-71E216F3218C Q51766085-9320018B-6DE9-47D9-B3BF-6639FEE43342 Q53398012-1EFE3A65-9EF5-45DF-8E7D-BB3905CE7319 Q53512833-14850CA3-5E7A-498A-9613-E780253252BB Q55617506-0D51955D-124B-4E26-98A9-9F74D89A9558 Q57291686-EA75FDA4-7CEE-4BED-9C51-5EFCA4BE2203 Q57291693-26DEF8CA-7200-4F65-8B58-5ED86B204A4F

P2860

Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

http://www.wikidata.org/entity/Q34714991

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@ast

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@en

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@nl

type

label

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@ast

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@en

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@nl

prefLabel

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@ast

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@en

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@nl

P1433

Q34714991-AAE1A7A8-003C-4D2C-A005-B48A738871A8

P1476

Q34714991-83153436-78B6-49FD-80CA-021AD7BE7787

P2093

Q34714991-16E7A577-7636-42B5-8111-92DC57FECFFD

Q34714991-1BACB328-C4A2-4B0B-9DC9-77D00BF693EB

Q34714991-28BCA17D-DB07-43C4-B585-1D181F292DAC

Q34714991-2A412135-D8A2-44BF-AFC4-C67E5DB9A167

Q34714991-2AA7A86F-E10B-45FD-B82C-05FAD9C0FFC7

Q34714991-425D850D-4944-4E20-94C3-ED8E186E29EC

Q34714991-9DB52D04-1570-454B-953A-586419B513A0

Q34714991-B92AFC47-1EEB-48D6-88EE-86346382938F

Q34714991-C05879EE-3DDC-422A-8E9F-1B1A10E25634

Q34714991-E5D75442-73A8-4417-B504-B66E2A0E4988

P2860

Q34714991-00C49869-5802-455D-83EC-5E0F2E0E8912

Q34714991-02807B8E-0322-47AE-83D7-4048CAD47C08

Q34714991-029EC918-5A9B-4434-92FF-B0CEE5BBCC5E

Q34714991-2D5C02DD-6352-4C65-A965-840527A6416F

Q34714991-319C43CB-0332-459F-B412-FA69651DC283

Q34714991-31C6D057-FBDE-4891-814C-D030B285F717

Q34714991-3338DE20-D03B-4436-87D5-70194BE5E292

Q34714991-36004622-C4C1-4924-BB61-14513AFDB17F

Q34714991-3A41F17E-DBF0-49CF-B913-D946CA57BD70

Q34714991-3C8D1BAB-BB2D-4310-9EC1-C802E1FCC6FD

P304

Q34714991-2C0E6E2A-94F6-49A9-80FB-78BA6B192A79

P31

Q34714991-32B0BC86-8A20-46D3-933B-5525420EAF6C

P356

Q34714991-A8B443EE-A64D-4909-A0B7-625A31E15EAB

P433

Q34714991-95771017-6E15-48D6-8CE5-7B4C752556CE

P478

Q34714991-671031D5-B275-4776-81BF-07806FCC7B48

P50

Q34714991-58A2235A-041B-4347-B154-11E6D5F8ADF5

Q34714991-84707746-22CA-4565-A604-8AC021E8224E

P577

Q34714991-42635C71-98FB-49F5-AA72-1476711F2752

P698

Q34714991-35FD343F-4344-42EC-95E3-6A0BAD8C7991

P921

Q34714991-178ADD7F-F2F0-400D-AB9D-9EE561EF95C2

Q34714991-20AA4034-638B-407C-9221-C43E991777F0

P932

Q34714991-5C851F58-533C-4F2F-989F-A941302A1785

P356

J.NEUROBIOLAGING.2014.07.019

P1433

Neurobiology of Aging

P1476

Reconsidering harbingers of de ...... Alzheimer's disease incidence.

@en

P2093

Adam M Brickman

http://www.w3.org/2001/XMLSchema#string

Atul Narkhede

http://www.w3.org/2001/XMLSchema#string

Erica Y Griffith

http://www.w3.org/2001/XMLSchema#string

Frank A Provenzano

http://www.w3.org/2001/XMLSchema#string

Irene B Meier

http://www.w3.org/2001/XMLSchema#string

Jennifer J Manly

http://www.w3.org/2001/XMLSchema#string

José A Luchsinger

http://www.w3.org/2001/XMLSchema#string

Laura B Zahodne

http://www.w3.org/2001/XMLSchema#string

Nicole Schupf

http://www.w3.org/2001/XMLSchema#string

Vanessa A Guzman

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Latent variable modeling of differences and changes with longitudinal data.

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.

Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?

White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

A pathophysiological framework of hippocampal dysfunction in ageing and disease

Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.

P304

27-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2014.07.019

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25155654

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4268124

http://www.w3.org/2001/XMLSchema#string